TP53 and neoplasm: Integrated HBV sequences often encode C-terminally truncated HBx proteins that disrupt cellular processes by activating signaling pathways or binding tumor suppressors like TP53, promoting tumorigenesis through angiogenesis, immune evasion, inflammation, and altered metabolism (32, 38, –, 40).